🟢 Harrow Health is trading 7.2% up in pre-market with no new company-specific catalyst identified

Harrow Health is trading at $31.50, up 7.18%, in pre-market on October 29, with no new company-specific catalyst identified.

• The price compares with the October 28 close of $29.39.
• Third-quarter results are due after the close on November 9, with a call on November 10.
• Healthcare-sector strength may be supportive, while broader-market indicators are mixed; the move’s specific cause remains unclear.